FDA approval of supplemental new drug application expanding the Furoscix (furosemide injection) indication in heart failure – sc Pharmaceuticals
scPharmaceuticals Inc. announced that the FDA has approved its Supplemental New Drug Application (sNDA) seeking to expand the Furoscix indication for heart failure patients. At approval, Furoscix was… read more.
